2024-511927-32-00已完成1 期
A Phase 1 study to look at RP-6306 in combination with FOLFIRI as a treatment for Advanced Solid Tumours
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 26
- 试验地点
- 4
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Nathan Hawkey, MD, MBA
Scientific
Repare Therapeutics USA Inc.
研究点 (4)
Loading locations...
相似试验
已完成
1 期
A Phase 1 Study of RO7623066 Alone and in Combination in Patients With Advanced Solid TumorsAdvanced Solid TumorsNCT05240898Hoffmann-La Roche116
招募中
1 期
Study of Lunresertib Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid TumorsAdvanced Solid TumorNCT04855656Debiopharm International SA464
终止
1 期
Study of RP-6306 With Gemcitabine in Advanced Solid TumorsAdult Solid TumorNCT05147272Debiopharm International SA67
进行中（未招募）
1 期
Phase 1 Study of RP-6306 With Carboplatin and Paclitaxel in TP53 Ovarian and Uterine CancerRecurrent Ovarian CancerRecurrent Uterine CancerMetastatic CancerAdvanced CancerNCT06107868University Health Network, Toronto6
已完成
1 期
Safety and Pharmacokinetic Study of PF-06651600 in Japanese Healthy VolunteersHealthyNCT03232905Pfizer6